anayamalik, Author at European Medical Journal - Page 103 of 128

COVID-19 in Pregnancy Linked to GDM Risk

COVID-19 infection during pregnancy may modestly increase the risk of developing gestational diabetes mellitus (GDM), a recent retrospective cohort study reveals.

Bridging Psoriatic Arthritis Communication Barriers

The way patients and clinicians prioritize different aspects of psoriatic arthritis (PsA) has been revealed in a new study that shed light on important disparities that could impact care quality and outcomes.

Safety Data for Beta Blockers in PHACE

A new systematic review has shed light on the safety of beta blockers for treating PHACE syndrome, addressing concerns about stroke risk in patients with cerebrovascular and cardiovascular anomalies.

New Nanotech Kills Tumors and Boosts Immunity

A new study has unveiled a groundbreaking cancer treatment approach using engineered extracellular vesicles to target both tumor cells and immunosuppressive stromal cells in the tumor microenvironment (TME).

New Guidelines Address Complexities in Neurosarcoidosis Care

Neurosarcoidosis, a rare and complex inflammatory disorder of the nervous system, presents unique challenges for diagnosis and treatment due to its variability and limited research.

Effectiveness of Antiviral Drugs for Nonsevere Influenza

A systematic review and meta-analysis evaluating antiviral medications for nonsevere influenza provides new insights into the optimal treatments for symptom relief and hospitalization risks, particularly for high-risk patients.

HMPV Epidemic in China: Should the U.S. Be Concerned?

Cases of human metapneumovirus (HMPV), a common respiratory virus, are surging in parts of Asia, including China, Malaysia, India, and Kazakhstan.

Salivary Biomarkers Aid in Sjögren’s Detection

A diagnostic model has been developed for primary Sjögren’s disease (pSjD), utilizing salivary biomarkers, serum autoantibodies, and Schirmer’s test.

Can Metformin Reduce Non-Melanoma Skin Cancer?

A recent study has highlighted metformin’s potential role in reducing the risk of non-melanoma skin cancers (NMSC), offering intriguing possibilities for dermatological and oncological care.

AI Boosts Breast Cancer Detection in Real-World Study

A recent observational study has shown that AI can significantly enhance breast cancer detection rates in mammography screening without increasing unnecessary recalls.